









市場行情
/
股票
/
nasdaq-livn
/

LivaNova PLC

LIVN

62.820USD

+0.740+1.19%

收盤 12/19, 16:00（美東）報價延遲15分鐘

3.43B總市值

虧損本益比TTM



LivaNova PLC

62.820

+0.740+1.19%

概覽公司財務分析

概覽

公司

財務

分析

關於 LivaNova PLC 公司

LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.

LivaNova PLC簡介



公司代碼LIVN

公司名稱LivaNova PLC

上市日期Oct 19, 2015

CEOMakatsaria (Vladimir A)

員工數量2900

證券類型Ordinary Share

年結日Oct 19

公司地址20 Eastbourne Terrace

城市LONDON

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United Kingdom

郵編W2 6LG

電話442033250662

網址https://www.livanova.com/

公司代碼LIVN

上市日期Oct 19, 2015

CEOMakatsaria (Vladimir A)

LivaNova PLC公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. William A. Kozy

Independent Chairman of the Board

32.57K

+15.05%

Mr. Alex Shvartsburg

Chief Financial Officer

26.68K

Ms. Stephanie Bolton

President, Global Epilepsy

12.75K

Dr. Sharon O'Kane, Ph.D.

Independent Director

11.30K

+19.06%

Mr. Todd C. Schermerhorn

Independent Director

9.06K

+49.63%

Mr. Francesco Bianchi

Independent Director

9.03K

-14.25%

Franco Poletti ,

President, Cardiopulmonary Business Unit

8.52K

+4.49%

Ms. Brooke Story

Independent Director

6.23K

-3.86%

Mr. Michael Damon Hutchinson

Senior Vice President, Chief Legal Officer, Company Secretary

5.67K

Ahmet Tezel

Senior Vice President, Chief Innovation Officer

1.94K

名稱

名稱/職務

職務

持股

持股變動

Mr. William A. Kozy

Independent Chairman of the Board

32.57K

+15.05%

Mr. Alex Shvartsburg

Chief Financial Officer

26.68K

Ms. Stephanie Bolton

President, Global Epilepsy

12.75K

Dr. Sharon O'Kane, Ph.D.

Independent Director

11.30K

+19.06%

Mr. Todd C. Schermerhorn

Independent Director

9.06K

+49.63%

Mr. Francesco Bianchi

Independent Director

9.03K

-14.25%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

由於公司未披露，未能獲取相關數據

地區USD

名稱

營收

佔比

United States

188.47M

53.46%

Rest of World

97.27M

27.59%

Europe

66.78M

18.94%

業務

地區

由於公司未披露，未能獲取相關數據

股東統計

更新時間: 11月16日週日

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

11.60%

PRIMECAP Management Company

8.14%

Millennium Management LLC

5.44%

Artisan Partners Limited Partnership

4.44%

Wellington Management Company, LLP

4.30%

其他

66.08%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

11.60%

PRIMECAP Management Company

8.14%

Millennium Management LLC

5.44%

Artisan Partners Limited Partnership

4.44%

Wellington Management Company, LLP

4.30%

其他

66.08%

股東類型

持股股東

佔比

Investment Advisor

49.17%

Investment Advisor/Hedge Fund

36.44%

Hedge Fund

13.06%

Research Firm

3.19%

Pension Fund

2.29%

Bank and Trust

1.34%

Individual Investor

0.37%

Sovereign Wealth Fund

0.09%

Insurance Company

0.04%

機構持股



更新時間: 10月5日週日

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

562

56.86M

104.13%

-8.50M

2025Q2

564

56.85M

104.11%

-6.95M

2025Q1

581

56.61M

103.82%

-8.04M

2024Q4

586

56.98M

104.84%

-8.56M

2024Q3

563

55.15M

101.56%

-9.48M

2024Q2

546

57.21M

105.64%

-8.52M

2024Q1

547

58.00M

107.51%

-6.90M

2023Q4

532

56.62M

105.11%

-7.28M

2023Q3

527

56.14M

104.20%

-8.51M

2023Q2

529

55.56M

103.33%

-9.55M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

6.37M

11.67%

-150.58K

-2.31%

Jun 30, 2025

PRIMECAP Management Company

4.64M

8.5%

+32.94K

+0.71%

Jun 30, 2025

Millennium Management LLC

2.43M

4.44%

+360.76K

+17.47%

Jun 30, 2025

Artisan Partners Limited Partnership

1.25M

2.29%

+661.48K

+112.86%

Jun 30, 2025

Wellington Management Company, LLP

1.28M

2.34%

+805.32K

+170.32%

Jun 30, 2025

The Vanguard Group, Inc.

2.44M

4.47%

-214.69K

-8.09%

Jun 30, 2025

State Street Investment Management (US)

2.08M

3.81%

-17.41K

-0.83%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

1.61M

2.96%

+282.33K

+21.20%

Jun 30, 2025

AQR Capital Management, LLC

2.05M

3.75%

+478.52K

+30.45%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.43M

2.62%

+18.55K

+1.31%

Jun 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

State Street SPDR S&P Health Care Equipment ETF

1.66%

JPMorgan Active Small Cap Value ETF

1.43%

Invesco NASDAQ Future Gen 200 ETF

0.5%

Simplify Health Care ETF

0.43%

Global X Aging Population ETF

0.42%

JPMorgan Fundamental Data Science Small Core ETF

0.37%

Avantis US Small Cap Equity ETF

0.34%

iShares U.S. Medical Devices ETF

0.34%

WisdomTree US SmallCap Fund

0.33%

Federated Hermes MDT Small Cap Core ETF

0.33%

State Street SPDR S&P Health Care Equipment ETF

佔比1.66%

JPMorgan Active Small Cap Value ETF

佔比1.43%

Invesco NASDAQ Future Gen 200 ETF

佔比0.5%

Simplify Health Care ETF

佔比0.43%

Global X Aging Population ETF

佔比0.42%

JPMorgan Fundamental Data Science Small Core ETF

佔比0.37%

Avantis US Small Cap Equity ETF

佔比0.34%

iShares U.S. Medical Devices ETF

佔比0.34%

WisdomTree US SmallCap Fund

佔比0.33%

Federated Hermes MDT Small Cap Core ETF

佔比0.33%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

LivaNova PLC的前五大股東是誰？



LivaNova PLC的前五大股東如下：
BlackRock Institutional Trust Company, N.A.
持有股份：6.37M
佔總股份比例：11.67%。
PRIMECAP Management Company
持有股份：4.64M
佔總股份比例：8.50%。
Millennium Management LLC
持有股份：2.43M
佔總股份比例：4.44%。
Artisan Partners Limited Partnership
持有股份：1.25M
佔總股份比例：2.29%。
Wellington Management Company, LLP
持有股份：1.28M
佔總股份比例：2.34%。